Resource Center
Resource Center
An alternative, more affordable hepatitis C treatment drugs cures 75% of patients who failed initial treatment in Rwanda
Read more
The CHAI 2023 Annual Report highlights our key roles as operational and strategic partners to governments, market shapers, and ecosystem catalysts within the global health space
Read more
CHAI's 2022 Annual Report is out now, commemorating 20 Years of Saving Lives.
Read more
Study shows that the COVID-19 rapid antigen test increased testing availability and case identification in Rwanda during the first year of the pandemic
Read moreCHAI and the governments of Indonesia, India, Myanmar, Nigeria, and Vietnam have published a manuscript identifying factors associated with patient outcomes among 100,000+ patients treated for hepatitis C.
Read more
CHAI's 2021 Annual Report is out now. In it, we recognize the incredible efforts of our staff during a difficult year.
Read more
The collaboration agreement includes provisions to work with ministries of health and other experts to strengthen hospital-based stewardship programs that ensure appropriate use. These provisions are especially important to avoid fueling resistance to cefiderocol.
Read more
CHAI supported the government of Zimbabwe to conduct a study published in the AIDS journal to examine whether the use of point-of-care (POC) VL testing at health facilities during pregnancy improved HIV viral suppression at delivery.
Read more
CHAI's 2020 Annual Report is out now. The theme for the year is 'working with urgency'.
Read more
The report provides market intelligence on hepatitis C diagnostics and drugs in low- and middle-income countries and covers preliminary insights into the hepatitis B market.
Read more